Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integration of HPV Vaccination and HPV-based Cervical Screening in Young Adult WLWH Into ARV Clinics to Speed the Pathway Towards Cervical Cancer Elimination: the H2VICTORY Trial

NCT05173324 is registered in ClinicalTrials.gov with International Agency for Research on Cancer as lead sponsor.

NCT NCT05173324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05173324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integration of HPV Vaccination and HPV-based Cervical Screening in Young Adult WLWH Into ARV Clinics to Speed the Pathway Towards Cervical Cancer Elimination: the H2VICTORY Trial
Lead sponsor
International Agency for Research on Cancer
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 1, 2023
Completion date
June 30, 2027
Enrollment
8,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection